Partial vs radical nephrectomy for T1 renal tumours: an analysis from the British Association of Urological Surgeons Nephrectomy Audit

BJU International
Marios HadjipavlouBAUS Sections of Endourology and Oncology

Abstract

To analyse and compare data from the British Association of Urological Surgeons Nephrectomy Audit for perioperative outcomes of partial (PN) and radical nephrectomy (RN) for T1 renal tumours. UK consultants were invited to submit data on all patients undergoing nephrectomy between 1 January and 31 December 2012 to a nationally established database using a standard pro forma. Analysis was made on patient demographics, operative technique, and perioperative data/outcome between PN and RN for T1 tumours. Overall, data from 6 042 nephrectomies were reported of which 1 768 were performed for T1 renal tumours. Of these, 1 082 (61.2%) were RNs and 686 (38.8%) were PNs. The mean age of patients undergoing PN was lower (PN 59 years vs RN 64 years; P < 0.001) and so was the WHO performance score (PN 0.4 vs RN 0.7; P < 0.001). PN for the treatment of T1a tumours (≤4 cm) accounted for 55.6% of procedures, of which 43.9% were performed using a minimally invasive technique. For T1b tumours (4-7 cm), 18.9% of patients underwent PN, in 33.3% of which a minimally invasive technique was adopted. The vast majority of RNs for T1 tumours were performed using a minimally invasive technique (90.3%). Of the laparoscopic PNs, 30.5% were robot-assisted....Continue Reading

References

Jan 25, 2006·BJU International·Kim DavenportUNKNOWN Members of the Baus Section of Endourology
May 15, 2008·Nature Clinical Practice. Urology·John S LamPeter G Schulam
Sep 9, 2008·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·L ZiniP Karakiewicz
Jan 20, 2009·The Journal of Urology·R Houston ThompsonPaul Russo
Feb 6, 2009·Cancer·Laurent ZiniPierre I Karakiewicz
Aug 7, 2009·European Urology·Frank BeckerMichael Stöckle
Aug 18, 2009·The Journal of Urology·Steven C CampbellUNKNOWN Practice Guidelines Committee of the American Urological Association
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Dec 6, 2011·European Urology·Martin MarszalekHendrik Van Poppel
Feb 11, 2012·Annals of Surgical Oncology·Maxine SunPierre I Karakiewicz
Mar 13, 2012·European Urology·Steven MacLennanUNKNOWN EAU Renal Cancer Guideline Panel
Jul 10, 2012·European Urology·Omar M AboumarzoukJihad H Kaouk
Jul 31, 2012·European Urology·Steven MacLennanUNKNOWN EAU Renal Cancer Guideline Panel
Feb 5, 2013·European Urology·Alexander KutikovRobert G Uzzo
Jul 23, 2014·Current Opinion in Urology·Matthias Waldert, Tobias Klatte
Aug 8, 2014·BJU International·Bl JacksonUNKNOWN British Association of Urological Surgeons (BAUS) - Section of Oncology
Aug 12, 2014·World Journal of Surgical Oncology·Julie SteinestelAndres Jan Schrader
Jan 27, 2015·European Urology·Borje LjungbergAxel Bex

❮ Previous
Next ❯

Citations

Jan 24, 2012·European Urology·Julien GuillotreauJihad H Kaouk
Nov 22, 2016·The Cancer Journal·S Brandon Hancock, Christos S Georgiades
Aug 10, 2017·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Ding PengLi-Qun Zhou
Sep 12, 2018·Minerva urologica e nefrologica = The Italian journal of urology and nephrology·Andrea MinerviniRiccardo Schiavina
Mar 1, 2019·International Journal of Urology : Official Journal of the Japanese Urological Association·Kenneth ChenJohn Shyi Peng Yuen
Nov 24, 2018·Journal of Robotic Surgery·Alexander J W BeulensCordula Wagner
Jun 27, 2020·Transplant International : Official Journal of the European Society for Organ Transplantation·Bulang HeWai Lim
Jul 1, 2017·Current Urology Reports·John WithingtonRavi Barod
Jul 28, 2018·World Journal of Urology·Sabrina H RossiGrant D Stewart
Dec 18, 2015·BJU International·Giacomo Novara, Alexander Mottrie
Jan 28, 2017·Indian Journal of Surgical Oncology·K Farrag, S Sriprasad
Nov 19, 2020·Journal of Clinical Medicine·Ching-Chia LiWen-Jeng Wu
Sep 18, 2021·Scandinavian Journal of Urology·Erkkilä KaisaHarry Nisen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.